Modeling of Effect of Glucose Sensor Errors on Insulin Dosage and Glucose Bolus Computed by LOGIC-Insulin
- 1 December 2014
- journal article
- research article
- Published by Oxford University Press (OUP) in Clinical Chemistry
- Vol. 60 (12) , 1510-1518
Abstract
Background: Effective and safe glycemic control in critically ill patients requires accurate glucose sensors and adequate insulin dosage calculators. The LOGIC-Insulin calculator for glycemic control has recently been validated in the LOGIC-1 randomized controlled trial. In this study, we aimed to determine the allowable error for intermittent and continuous glucose sensors, on the basis of the LOGIC-Insulin calculator. Methods: A gaussian simulation model with a varying bias (0%–20%) and CV (−20% to +20%) simulated blood glucose values from the LOGIC-1 study (n = 149 patients) in 10 Monte Carlo steps. A clinical error grid system was developed to compare the simulated LOGIC-Insulin–directed intervention with the nominal intervention (0% bias, 0% CV). The severity of error measuring the clinical effect of the simulated LOGIC-Insulin intervention was graded as type B, C, and D errors. Type D errors were classified as acutely life-threatening (0% probability preferred). Results: The probability of all types of errors was lower for continuous sensors compared with intermittent sensors. The maximum total error (TE), defined as the first TE introducing a type B/C/D error, was similar for both sensor types. To avoid type D errors, TEs Conclusions: Continuous sensors had a lower probability for clinical errors than intermittent sensors at the same accuracy level. These simulations demonstrated the suitability of the LOGIC-Insulin control system for use with continuous, as well as intermittent, sensors.Keywords
Funding Information
- KU Leuven (IOF-HB-10/039)
- KU Leuven (IOF-HB-13/027)
This publication has 33 references indexed in Scilit:
- A prospective randomised multi-centre controlled trial on tight glucose control by intensive insulin therapy in adult intensive care units: the Glucontrol studyIntensive Care Medicine, 2009
- Intensive versus Conventional Glucose Control in Critically Ill PatientsNew England Journal of Medicine, 2009
- Intensive insulin therapy for patients in paediatric intensive care: a prospective, randomised controlled studyThe Lancet, 2009
- Early blood glucose control and mortality in critically ill patients in Australia*Critical Care Medicine, 2009
- Hyperglycemia and Acute Coronary SyndromeCirculation, 2008
- Intensive Insulin Therapy and Pentastarch Resuscitation in Severe SepsisNew England Journal of Medicine, 2008
- Intensive Insulin Protocol Improves Glucose Control and Is Associated with a Reduction in Intensive Care Unit MortalityJournal of the American College of Surgeons, 2007
- Intensive Insulin Therapy in the Medical ICUNew England Journal of Medicine, 2006
- Effect of an Intensive Glucose Management Protocol on the Mortality of Critically Ill Adult PatientsMayo Clinic Proceedings, 2004
- Intensive Insulin Therapy in Critically Ill PatientsNew England Journal of Medicine, 2001